PPARG and neoplasm: Separately, by suppressing matrix metalloproteinases and antagonizing Smad3-dependent transcriptional activity, PPARγ also attenuates extracellular matrix (ECM) remodeling and epithelial–mesenchymal transition (EMT), which, in turn, leads to reduced tumor metastasis [31,32].